Johnathan Doe
PatientMRN: 12345678 • Age: 45 • Sex: Male • DOB: 05/12/1978
analytics Calculated Risk Score
High Risk
Last Score
70%
Confidence
94.2%
Status
Critical
Clinical Parameters
4 Abnormalities Detected| Biomarker | Result | Reference Range | Status |
|---|---|---|---|
| LDL Cholesterol | 185 mg/dL | < 100 mg/dL | High |
| Blood Pressure | 158/94 mmHg | < 120/80 mmHg | Stage 2 |
| Glucose (Fasting) | 92 mg/dL | 70-99 mg/dL | Normal |
| HbA1c | 6.1% | < 5.7% | Pre-diabetic |
| BMI | 31.4 kg/m² | 18.5-24.9 kg/m² | Obese |
psychology Clinical Narratives
Cardiovascular Assessment
Priority: High
Patient displays a high risk score primarily driven by synergistic interaction between Hypertension (158/94) and elevated LDL levels. The combined presence of these factors significantly increases the 10-year risk of major adverse cardiovascular events (MACE).
Metabolic & Endocrine
Priority: Medium
Fasting glucose is within range, however HbA1c (6.1%) indicates a sustained glycemic load consistent with pre-diabetes. Coupled with a BMI of 31.4, weight management and carb-restricted dietary intervention are highly recommended to prevent progression to Type 2 Diabetes.
Liver & Renal Profile
Priority: Stable
Hepatic and renal function parameters remain within optimal ranges. GFR and Creatinine levels do not indicate impairment, suggesting that current blood pressure elevation has not yet induced nephropathy.
Next Steps
Based on these findings, we recommend scheduling a Cardiology consult within 14 days.